Originally published In Press as doi:10.1074/mcp.M500207-MCP200 on September 30, 2005.
Molecular & Cellular Proteomics 4:2000-2009, 2005.
© 2005 by The American Society for Biochemistry and Molecular Biology, Inc.
Research
Comparative Proteomic Analysis of Intra- and Interindividual Variation in Human Cerebrospinal Fluid*,S
Yan Hu , ,¶,
James P. Malone||,
Anne M. Fagan , ,
R. Reid Townsend|| and
David M. Holtzman , ,**,
From the Department of Neurology, Hope Center for Neurological Disorders, || Department of Medicine, Division of Metabolism and Proteomics Center, and ** Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, Missouri 63110
Cerebrospinal fluid (CSF) is a potential source of biomarkers for many disorders of the central nervous system, including Alzheimer disease (AD). Prior to comparing CSF samples between individuals to identify patterns of disease-associated proteins, it is important to examine variation within individuals over a short period of time so that one can better interpret potential changes in CSF between individuals as well as changes within a given individual over a longer time span. In this study, we analyzed 12 CSF samples, composed of pairs of samples from six individuals, obtained 2 weeks apart. Multiaffinity depletion, two-dimensional DIGE, and tandem mass spectrometry were used. A number of proteins whose abundance varied between the two time points was identified for each individual. Some of these proteins were commonly identified in multiple individuals. More importantly, despite the intraindividual variations, hierarchical clustering and multidimensional scaling analysis of the proteomic profiles revealed that two CSF samples from the same individual cluster the closest together and that the between-subject variability is much larger than the within-subject variability. Among the six subjects, comparison between the four cognitively normal and the two very mildly demented subjects also yielded some proteins that have been identified in previous AD biomarker studies. These results validate our method of identifying differences in proteomic profiles of CSF samples and have important implications for the design of CSF biomarker studies for AD and other central nervous system disorders.
 To whom correspondence should be addressed: Dept. of Neurology, 660 S. Euclid Ave., Campus Box 8111, St. Louis, MO 63110. Tel.: 314-362-9872; Fax: 314-362-2244; E-mail: holtzman{at}neuro.wustl.edu

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. M. Umstead, W. M. Freeman, V. M. Chinchilli, and D. S. Phelps
Age-related changes in the expression and oxidation of bronchoalveolar lavage proteins in the rat
Am J Physiol Lung Cell Mol Physiol,
January 1, 2009;
296(1):
L14 - L29.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Yamakawa, K. Yoshida, H. Nishikawa, T. Kato, and T. Iwamoto
Comparative Analysis of Interindividual Variations in the Seminal Plasma Proteome of Fertile Men With Identification of Potential Markers for Azoospermia in Infertile Patients
J Androl,
November 1, 2007;
28(6):
858 - 865.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Liu, W.-J. Qian, M. A. Gritsenko, W. Xiao, L. L. Moldawer, A. Kaushal, M. E. Monroe, S. M. Varnum, R. J. Moore, S. O. Purvine, et al.
High Dynamic Range Characterization of the Trauma Patient Plasma Proteome
Mol. Cell. Proteomics,
October 1, 2006;
5(10):
1899 - 1913.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-J. Qian, J. M. Jacobs, T. Liu, D. G. Camp II, and R. D. Smith
Advances and Challenges in Liquid Chromatography-Mass Spectrometry-based Proteomics Profiling for Clinical Applications
Mol. Cell. Proteomics,
October 1, 2006;
5(10):
1727 - 1744.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|